Cybin Inc.
PublicCybin Inc. is now publicly traded
The data on this page reflects Cybin Inc.'s private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
Private Placement
Mar 10, 2026
Total Funding Raised
$3.57M
Company Overview
Cybin Inc. operates in Healthcare and is based in Toronto, Ontario. It has raised $3.57M.
Cybin Inc. is a clinical-stage pharmaceutical company that develops proprietary novel serotonergic agonists for the treatment of mental health disorders.
Sector
Healthcare
AI Layer
Non-AI
Cybin Inc. Comparables
Compare Cybin Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Reunion Neuroscience Inc. | 85% | |
| Eli Lilly and Company | 85% | |
| Ceruvia Lifesciences | 83% |
For institutional investors. Book with your work email.
Cybin Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Placement | Mar 10, 2026 | ||||
| Private Placement | Mar 8, 2022 | ||||
| Private Placement | Mar 4, 2022 | ||||
| Private Placement | Dec 14, 2020 | ||||
| Private Placement | Nov 27, 2020 |
For institutional investors. Book with your work email.
Cybin Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RA Capital Management | Private Placement |
| Rosalind Advisors | Private Placement |
| Altium Capital | Private Placement |
| Deep Track Capital | Private Placement |
| Logos Capital | Private Placement |
| Acorn Bioventures | Private Placement |
| Octagon Capital Advisors | Private Placement |
For institutional investors. Book with your work email.
Cybin Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.